US-based biotechnology company United Therapeutics has obtained an approval from the US Food and Drug Administration (FDA) for the Orenitram (treprostinil) extended-release tablets, indicted for the treatment of pulmonary arterial ...
Tags: Extended-Release Tablets, Medicine
United Therapeutics has received complete response letter (CRL) from the FDA for an oral formulation of Remodulin (treprostinil). Treprostinil is indicated for pulmonary arterial hypertension (PAH) that is at present available in ...
Tags: Medicine, Treprostinil